ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,345Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 229

$874K Total Retail Price of All Prescriptions

Rank: 6 out of 229

699 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 11,958 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 627 576 1 1
LISINOPRIL 500 459 2 2
SIMVASTATIN 448 405 3 3
METFORMIN HCL 440 390 4 6
OMEPRAZOLE 427 351 5 4
AMLODIPINE BESYLATE 421 387 6 5
ALENDRONATE SODIUM 393 364 7 14
LOVASTATIN 370 325 8 11
GABAPENTIN 333 237 9 10
ZOLPIDEM TARTRATE 302 257 10 20
FINASTERIDE 277 266 11 55
DOXAZOSIN MESYLATE 250 217 12 50
METOPROLOL TARTRATE 230 206 13 13
FUROSEMIDE 216 181 14 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 185 15 28
ATORVASTATIN CALCIUM 198 172 16 15
METOPROLOL SUCCINATE 197 156 17 16
DONEPEZIL HCL 183 183 18 29
HYDROCHLOROTHIAZIDE 170 152 19 9
TRAZODONE HCL 168 99 20 34
OXYCODONE HCL 163 98 S2 21 37
HYDROCODONE-ACETAMINOPHEN 148 93 S3 22 7
LOSARTAN POTASSIUM 143 138 23 12
CRESTOR 140 135 24 30
ENDOCET 136 116 S2 25 135
IBUPROFEN 135 80 26 60
GLIPIZIDE 126 120 27 36
CYMBALTA 122 90 28 64
NAMENDA 119 116 29 39
ALLOPURINOL 114 93 30 27
RANITIDINE HCL 110 100 31 32
TRAMADOL HCL 101 81 32 26
ESCITALOPRAM OXALATE 100 69 33 98
LIDOCAINE 96 83 34 241
LOSARTAN-HYDROCHLOROTHIAZIDE 93 91 35 65
FENOFIBRATE 91 71 36 68
CITALOPRAM HBR 90 86 37 21
LANTUS 90 53 37 40
FLUOXETINE HCL 84 48 39 41
CARVEDILOL 83 75 40 31
CYCLOBENZAPRINE HCL 81 48 R 41 75
DETROL LA 80 76 42 125
AMITRIPTYLINE HCL 79 71 R 43 66
TRIAMCINOLONE ACETONIDE 77 63 44 113
VENTOLIN HFA 77 58 44 181
OXYCODONE-ACETAMINOPHEN 76 62 S2 46 43
CELEBREX 76 72 46 71
POTASSIUM CHLORIDE 75 63 48 18
DOXYCYCLINE HYCLATE 69 59 49 102
JANUVIA 69 50 49 59
FLUTICASONE PROPIONATE 68 62 51 23
INSULIN SYRINGE 67 40 52 83
BACLOFEN 67 34 52 107
ADVAIR DISKUS 65 57 54 47
SYMBICORT 65 56 54 118
SINGULAIR 64 56 56 119
CLONIDINE HCL 62 51 57 69
TRIAMTERENE-HYDROCHLOROTHIAZID 62 47 57 223
TAMSULOSIN HCL 61 58 59 24
IMIPRAMINE HCL 59 59 R 60 272
FELODIPINE ER 58 55 61 61
ATENOLOL 58 58 61 19
ENALAPRIL MALEATE 58 43 61 54
GLYBURIDE 58 57 R 61 57
CLOTRIMAZOLE-BETAMETHASONE 54 45 65 171
LEVOTHROID 54 40 65 130
AGGRENOX 52 52 67 157
EVISTA 52 52 67 106
HYDROXYZINE HCL 52 27 R 67 165
SERTRALINE HCL 50 44 70 22
ZOLPIDEM TARTRATE ER 50 45 70 308
CIPROFLOXACIN HCL 50 46 70 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.